305 related articles for article (PubMed ID: 18266634)
1. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
2. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
3. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
[TBL] [Abstract][Full Text] [Related]
5. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
6. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
7. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.
Gruber S; Frey R; Mlynárik V; Stadlbauer A; Heiden A; Kasper S; Kemp GJ; Moser E
Invest Radiol; 2003 Jul; 38(7):403-8. PubMed ID: 12821853
[TBL] [Abstract][Full Text] [Related]
8. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
[TBL] [Abstract][Full Text] [Related]
9. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
10. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
[TBL] [Abstract][Full Text] [Related]
11. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics.
Seitz D; Widmann U; Seeger U; Nägele T; Klose U; Mann K; Grodd W
Alcohol Clin Exp Res; 1999 Jan; 23(1):158-63. PubMed ID: 10029218
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
[TBL] [Abstract][Full Text] [Related]
13. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.
Naegele T; Grodd W; Viebahn R; Seeger U; Klose U; Seitz D; Kaiser S; Mader I; Mayer J; Lauchart W; Gregor M; Voigt K
Radiology; 2000 Sep; 216(3):683-91. PubMed ID: 10966695
[TBL] [Abstract][Full Text] [Related]
14. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
15. Proton spectroscopy of brain glutamine in acute liver failure.
McConnell JR; Antonson DL; Ong CS; Chu WK; Fox IJ; Heffron TG; Langnas AN; Shaw BW
Hepatology; 1995 Jul; 22(1):69-74. PubMed ID: 7601435
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
Reynolds NC; Prost RW; Mark LP
Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
[TBL] [Abstract][Full Text] [Related]
17. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M; Horsman A
Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities.
Sinha S; Misra A; Kumar V; Jagannathan NR; Bal CS; Pandey RM; Singhania R; Deepak
Clin Endocrinol (Oxf); 2004 Aug; 61(2):182-9. PubMed ID: 15272912
[TBL] [Abstract][Full Text] [Related]
19. Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy.
Thomas MA; Huda A; Guze B; Curran J; Bugbee M; Fairbanks L; Ke Y; Oshiro T; Martin P; Fawzy F
AJR Am J Roentgenol; 1998 Oct; 171(4):1123-30. PubMed ID: 9763008
[TBL] [Abstract][Full Text] [Related]
20. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.
Frey BN; Folgierini M; Nicoletti M; Machado-Vieira R; Stanley JA; Soares JC; Kapczinski F
Hum Psychopharmacol; 2005 Mar; 20(2):133-9. PubMed ID: 15648094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
